CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 22397 | LVS EN 13612:2003 /AC:2003 | Performance evaluation of in vitro diagnostic medical devices | Standarts spēkā |
| 74322 | LVS CEN ISO/TS 5798:2023 | In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022) | Standarts spēkā |
| 64279 | LVS EN ISO 22367:2020 | Medical laboratories - Application of risk management to medical laboratories (ISO 22367:2020) | Standarts spēkā |
| 77643 | EN ISO 5649:2024 | Medical laboratories - Concepts and specifications for the design, development, implementation, and use of laboratory-developed tests (ISO 5649:2024) | Standarts spēkā |
| 61390 | LVS EN ISO 15195:2019 | Laboratory medicine - Requirements for the competence of calibration laboratories using reference measurement procedures (ISO 15195:2018) | Standarts spēkā |
| 79016 | LVS EN ISO 15189:2022/A11:2023 | Medical laboratories - Requirements for quality and competence | Standarts spēkā |
| 62263 | EN ISO 17511:2021 | In vitro diagnostic medical devices - Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples (ISO/DIS 17511:2019) | Standarts spēkā |
| 61692 | LVS EN ISO 6710:2017 | Single-use containers for human venous blood specimen collection (ISO 6710:2017) | Standarts spēkā |
| 76940 | CEN ISO/TS 7552-2:2024 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood - Part 2: Isolated DNA (ISO/TS 7552-2:2024) | Standarts spēkā |
| 61691 | LVS EN ISO 20166-3:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 3: Isolated DNA (ISO 20166-3:2018) | Standarts spēkā |
Displaying 241-250 of 275 results.